Global Porcine Epidemic Diarrhea Vaccines Market Research Report 2023

Publisher Name :
Date: 11-Oct-2023
No. of pages: 85
Inquire Before Buying

Porcine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease. 

According to QYResearch's new survey, global Porcine Epidemic Diarrhea Vaccines market is projected to reach US$ 244.7 million in 2029, increasing from US$ 154 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Porcine Epidemic Diarrhea Vaccines market research.

Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Porcine Epidemic Diarrhea Vaccines market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

By Company

- CAVAC

- Green Cross Veterinary Products

- Harrisvaccines

- Komipharm

- Nisseiken

- Qilu Animal Health

- Zoetis

Segment by Type

- Live Vaccines

- Killed Vaccines

Segment by Application

- Piglets

- Adults Pigs

Consumption by Region

- North America

- - the United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

The Porcine Epidemic Diarrhea Vaccines report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Manufacturers' Competition Patterns

Chapter 3: Country Level Sales Analysis

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6: Manufacturers' Outline

Chapter 7: Industry Chain, Market Channel and Customer Analysis

Chapter 8: Market Opportunities and Challenges

Chapter 9: Market Conclusions

Chapter 10: Research Methodology and Data Source

Global Porcine Epidemic Diarrhea Vaccines Market Research Report 2023

Table of Contents
1 Porcine Epidemic Diarrhea Vaccines Market Overview
1.1 Product Overview and Scope of Porcine Epidemic Diarrhea Vaccines
1.2 Porcine Epidemic Diarrhea Vaccines Segment by Type
1.2.1 Global Porcine Epidemic Diarrhea Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Porcine Epidemic Diarrhea Vaccines Segment by Application
1.3.1 Global Porcine Epidemic Diarrhea Vaccines Market Value by Application: (2023-2029)
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Global Porcine Epidemic Diarrhea Vaccines Market Size Estimates and Forecasts
1.4.1 Global Porcine Epidemic Diarrhea Vaccines Revenue 2018-2029
1.4.2 Global Porcine Epidemic Diarrhea Vaccines Sales 2018-2029
1.4.3 Global Porcine Epidemic Diarrhea Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Porcine Epidemic Diarrhea Vaccines Market Competition by Manufacturers
2.1 Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Porcine Epidemic Diarrhea Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Porcine Epidemic Diarrhea Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Porcine Epidemic Diarrhea Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Epidemic Diarrhea Vaccines, Product Type & Application
2.7 Porcine Epidemic Diarrhea Vaccines Market Competitive Situation and Trends
2.7.1 Porcine Epidemic Diarrhea Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Porcine Epidemic Diarrhea Vaccines Players Market Share by Revenue
2.7.3 Global Porcine Epidemic Diarrhea Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Porcine Epidemic Diarrhea Vaccines Retrospective Market Scenario by Region
3.1 Global Porcine Epidemic Diarrhea Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Porcine Epidemic Diarrhea Vaccines Global Porcine Epidemic Diarrhea Vaccines Sales by Region: 2018-2029
3.2.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Region: 2018-2023
3.2.2 Global Porcine Epidemic Diarrhea Vaccines Sales by Region: 2024-2029
3.3 Global Porcine Epidemic Diarrhea Vaccines Global Porcine Epidemic Diarrhea Vaccines Revenue by Region: 2018-2029
3.3.1 Global Porcine Epidemic Diarrhea Vaccines Revenue by Region: 2018-2023
3.3.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Region: 2024-2029
3.4 North America Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.4.1 North America Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2018-2029)
3.4.3 North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.5.1 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2018-2029)
3.5.3 Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.7.1 Latin America Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Porcine Epidemic Diarrhea Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2018-2029)
4.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2018-2023)
4.1.2 Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2024-2029)
4.1.3 Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2018-2029)
4.2.1 Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2018-2023)
4.2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2024-2029)
4.2.3 Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Porcine Epidemic Diarrhea Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2018-2029)
5.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2018-2023)
5.1.2 Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2024-2029)
5.1.3 Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2018-2029)
5.2.1 Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2018-2023)
5.2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2024-2029)
5.2.3 Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Porcine Epidemic Diarrhea Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 CAVAC
6.1.1 CAVAC Corporation Information
6.1.2 CAVAC Description and Business Overview
6.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.1.5 CAVAC Recent Developments/Updates
6.2 Green Cross Veterinary Products
6.2.1 Green Cross Veterinary Products Corporation Information
6.2.2 Green Cross Veterinary Products Description and Business Overview
6.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.2.5 Green Cross Veterinary Products Recent Developments/Updates
6.3 Harrisvaccines
6.3.1 Harrisvaccines Corporation Information
6.3.2 Harrisvaccines Description and Business Overview
6.3.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.3.5 Harrisvaccines Recent Developments/Updates
6.4 Komipharm
6.4.1 Komipharm Corporation Information
6.4.2 Komipharm Description and Business Overview
6.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.4.5 Komipharm Recent Developments/Updates
6.5 Nisseiken
6.5.1 Nisseiken Corporation Information
6.5.2 Nisseiken Description and Business Overview
6.5.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.5.5 Nisseiken Recent Developments/Updates
6.6 Qilu Animal Health
6.6.1 Qilu Animal Health Corporation Information
6.6.2 Qilu Animal Health Description and Business Overview
6.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.6.5 Qilu Animal Health Recent Developments/Updates
6.7 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Porcine Epidemic Diarrhea Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zoetis Porcine Epidemic Diarrhea Vaccines Product Portfolio
6.7.5 Zoetis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Epidemic Diarrhea Vaccines Industry Chain Analysis
7.2 Porcine Epidemic Diarrhea Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Epidemic Diarrhea Vaccines Production Mode & Process
7.4 Porcine Epidemic Diarrhea Vaccines Sales and Marketing
7.4.1 Porcine Epidemic Diarrhea Vaccines Sales Channels
7.4.2 Porcine Epidemic Diarrhea Vaccines Distributors
7.5 Porcine Epidemic Diarrhea Vaccines Customers
8 Porcine Epidemic Diarrhea Vaccines Market Dynamics
8.1 Porcine Epidemic Diarrhea Vaccines Industry Trends
8.2 Porcine Epidemic Diarrhea Vaccines Market Drivers
8.3 Porcine Epidemic Diarrhea Vaccines Market Challenges
8.4 Porcine Epidemic Diarrhea Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Porcine Epidemic Diarrhea Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Porcine Epidemic Diarrhea Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Porcine Epidemic Diarrhea Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Porcine Epidemic Diarrhea Vaccines Sales (M Units) of Key Manufacturers (2018-2023)
Table 5. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Porcine Epidemic Diarrhea Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Porcine Epidemic Diarrhea Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Porcine Epidemic Diarrhea Vaccines Average Price (USD/K Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Porcine Epidemic Diarrhea Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Porcine Epidemic Diarrhea Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Porcine Epidemic Diarrhea Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Porcine Epidemic Diarrhea Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Porcine Epidemic Diarrhea Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Epidemic Diarrhea Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Porcine Epidemic Diarrhea Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Porcine Epidemic Diarrhea Vaccines Sales by Region (2018-2023) & (M Units)
Table 18. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Porcine Epidemic Diarrhea Vaccines Sales by Region (2024-2029) & (M Units)
Table 20. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Porcine Epidemic Diarrhea Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Porcine Epidemic Diarrhea Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Porcine Epidemic Diarrhea Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2018-2023) & (M Units)
Table 27. North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2024-2029) & (M Units)
Table 28. North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2018-2023) & (M Units)
Table 32. Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2024-2029) & (M Units)
Table 33. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Region (2018-2023) & (M Units)
Table 37. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Porcine Epidemic Diarrhea Vaccines Sales by Country (2018-2023) & (M Units)
Table 42. Latin America Porcine Epidemic Diarrhea Vaccines Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Country (2018-2023) & (M Units)
Table 47. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Porcine Epidemic Diarrhea Vaccines Sales (M Units) by Type (2018-2023)
Table 51. Global Porcine Epidemic Diarrhea Vaccines Sales (M Units) by Type (2024-2029)
Table 52. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Porcine Epidemic Diarrhea Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Porcine Epidemic Diarrhea Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Porcine Epidemic Diarrhea Vaccines Price (USD/K Unit) by Type (2018-2023)
Table 59. Global Porcine Epidemic Diarrhea Vaccines Price (USD/K Unit) by Type (2024-2029)
Table 60. Global Porcine Epidemic Diarrhea Vaccines Sales (M Units) by Application (2018-2023)
Table 61. Global Porcine Epidemic Diarrhea Vaccines Sales (M Units) by Application (2024-2029)
Table 62. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Porcine Epidemic Diarrhea Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Porcine Epidemic Diarrhea Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Porcine Epidemic Diarrhea Vaccines Price (USD/K Unit) by Application (2018-2023)
Table 69. Global Porcine Epidemic Diarrhea Vaccines Price (USD/K Unit) by Application (2024-2029)
Table 70. CAVAC Corporation Information
Table 71. CAVAC Description and Business Overview
Table 72. CAVAC Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 73. CAVAC Porcine Epidemic Diarrhea Vaccines Product
Table 74. CAVAC Recent Developments/Updates
Table 75. Green Cross Veterinary Products Corporation Information
Table 76. Green Cross Veterinary Products Description and Business Overview
Table 77. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 78. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product
Table 79. Green Cross Veterinary Products Recent Developments/Updates
Table 80. Harrisvaccines Corporation Information
Table 81. Harrisvaccines Description and Business Overview
Table 82. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 83. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product
Table 84. Harrisvaccines Recent Developments/Updates
Table 85. Komipharm Corporation Information
Table 86. Komipharm Description and Business Overview
Table 87. Komipharm Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 88. Komipharm Porcine Epidemic Diarrhea Vaccines Product
Table 89. Komipharm Recent Developments/Updates
Table 90. Nisseiken Corporation Information
Table 91. Nisseiken Description and Business Overview
Table 92. Nisseiken Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 93. Nisseiken Porcine Epidemic Diarrhea Vaccines Product
Table 94. Nisseiken Recent Developments/Updates
Table 95. Qilu Animal Health Corporation Information
Table 96. Qilu Animal Health Description and Business Overview
Table 97. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 98. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product
Table 99. Qilu Animal Health Recent Developments/Updates
Table 100. Zoetis Corporation Information
Table 101. Zoetis Description and Business Overview
Table 102. Zoetis Porcine Epidemic Diarrhea Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2023)
Table 103. Zoetis Porcine Epidemic Diarrhea Vaccines Product
Table 104. Zoetis Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Porcine Epidemic Diarrhea Vaccines Distributors List
Table 108. Porcine Epidemic Diarrhea Vaccines Customers List
Table 109. Porcine Epidemic Diarrhea Vaccines Market Trends
Table 110. Porcine Epidemic Diarrhea Vaccines Market Drivers
Table 111. Porcine Epidemic Diarrhea Vaccines Market Challenges
Table 112. Porcine Epidemic Diarrhea Vaccines Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Porcine Epidemic Diarrhea Vaccines
Figure 2. Global Porcine Epidemic Diarrhea Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Porcine Epidemic Diarrhea Vaccines Market Share by Type in 2022 & 2029
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Porcine Epidemic Diarrhea Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Porcine Epidemic Diarrhea Vaccines Market Share by Application in 2022 & 2029
Figure 8. Piglets
Figure 9. Adults Pigs
Figure 10. Global Porcine Epidemic Diarrhea Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Porcine Epidemic Diarrhea Vaccines Market Size (2018-2029) & (US$ Million)
Figure 12. Global Porcine Epidemic Diarrhea Vaccines Sales (2018-2029) & (M Units)
Figure 13. Global Porcine Epidemic Diarrhea Vaccines Average Price (USD/K Unit) & (2018-2029)
Figure 14. Porcine Epidemic Diarrhea Vaccines Report Years Considered
Figure 15. Porcine Epidemic Diarrhea Vaccines Sales Share by Manufacturers in 2022
Figure 16. Global Porcine Epidemic Diarrhea Vaccines Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Porcine Epidemic Diarrhea Vaccines Players: Market Share by Revenue in 2022
Figure 18. Porcine Epidemic Diarrhea Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Porcine Epidemic Diarrhea Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2018-2029)
Figure 21. North America Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2018-2029)
Figure 22. the United States Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2018-2029)
Figure 25. Europe Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2018-2029)
Figure 26. Germany Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2018-2029)
Figure 33. China Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2018-2029)
Figure 43. Latin America Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Porcine Epidemic Diarrhea Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Porcine Epidemic Diarrhea Vaccines by Type (2018-2029)
Figure 53. Global Revenue Market Share of Porcine Epidemic Diarrhea Vaccines by Type (2018-2029)
Figure 54. Global Porcine Epidemic Diarrhea Vaccines Price (USD/K Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Porcine Epidemic Diarrhea Vaccines by Application (2018-2029)
Figure 56. Global Revenue Market Share of Porcine Epidemic Diarrhea Vaccines by Application (2018-2029)
Figure 57. Global Porcine Epidemic Diarrhea Vaccines Price (USD/K Unit) by Application (2018-2029)
Figure 58. Porcine Epidemic Diarrhea Vaccines Value Chain
Figure 59. Porcine Epidemic Diarrhea Vaccines Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs